Antigen-presenting particle technology using inactivated surface-engineered viruses: induction of immune responses against infectious agents

BACKGROUND: Developments in cell-based and gene-based therapies are emerging as highly promising areas to complement pharmaceuticals, but present day approaches are too cumbersome and thereby limit their clinical usefulness. These shortcomings result in procedures that are too complex and too costly...

Descripción completa

Detalles Bibliográficos
Autores principales: Mosca, Joseph D, Chang, Yung-Nien, Williams, Gregory
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1885814/
https://www.ncbi.nlm.nih.gov/pubmed/17504532
http://dx.doi.org/10.1186/1742-4690-4-32

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1885814/
https://www.ncbi.nlm.nih.gov/pubmed/17504532
http://dx.doi.org/10.1186/1742-4690-4-32

Ejemplares similares